ADC Development Solutions

ADC Development Solutions

ADC drugs, or Antibody-Drug Conjugates, are a class of pharmaceuticals formed by chemically linking small molecule drugs with biologically active antibodies. Throughout the ADC drug development process, key stages include target selection, antibody discovery and optimization, quality control, and clinical research.

With years of experience in protein, antibody, and ELISA kit development, CUSABIO can tailor products, services, and solutions to meet customer needs at various stages of ADC drug development.

ADC Development Solutions

Early Development Stage

In the early stages of ADC drug development, the antibody component of the ADC drug must selectively bind to antigens on the surface of tumor cells, achieving precise targeting effects. Consequently, the preparation of highly pure and active target antigen proteins forms the foundation for ADC drug development. These target antigens are employed in screening and validating antibody specificity, as well as assessing in vitro cytotoxicity of ADC drugs and conducting cell function validations. The construction of stable cell lines is also a critical step in ADC drug development, applicable to target and pathway research, among other applications.

ADC Target Antigen Protein Products and Customized Services
ADC Target

ADC drugs, or Antibody-Drug Conjugates, are a class of pharmaceuticals formed by chemically linking small molecule drugs with biologically active antibodies. Throughout the ADC drug development process, key stages include target selection, antibody discovery and optimization, quality control, and clinical research.

With years of experience in protein, antibody, and ELISA kit development, CUSABIO can tailor products, services, and solutions to meet customer needs at various stages of ADC drug development.

Click to view existing Protein Products Custom service
Stable Cell Lines and Customization Services
Stable Cell Lines

Stable cell line construction refers to the integration of exogenous genes into recipient cells and their stable expression on the host cell membrane over the long term. Stable Cell Lines play a crucial role in biological research, widely used in applications such as recombinant protein and monoclonal antibody production, drug screening, and gene function studies.

With years of experience in protein expression research, CUSABIO has accumulated extensive experience in the development of Stable Cell Lines. We can effectively enhance the production capacity of Stable Cell Lines and improve experimental results. We now offer a range of stable cell line products targeting common drug targets, as well as one-stop services from gene sequence to stable line delivery for overexpression Stable Cell Lines and reporter gene cell lines.

Click to view existing products Stable Cell Line Development Service

Antibody Discovery and Optimization Stage

The objective of the antibody discovery and optimization stage is to obtain high-affinity, highly specific monoclonal antibodies targeting specific antigens. This forms the basis for ADC drugs to achieve precise targeting and efficient eradication of cancer cells. CUSABIO offers DT3C recombinant proteins, serving as an efficient tool for assessing antibody internalization efficiency. This tool enables the rapid and accurate screening of antibody candidates with high internalization efficiency, significantly enhancing the efficiency and success rate of antibody selection. Our Therapeutic Antibody discovery service provides a comprehensive solution from target identification to therapeutic antibody candidates, establishing a solid foundation for subsequent drug development. Customized ELISA kits are designed to offer highly specific and sensitive detection reagents, thereby improving the efficiency of antibody screening and evaluation.

Antibody Internalization Efficiency Assessment Tool - DT3C Recombinant Protein
DT3C Recombinant Protein

DT3C is a recombinant protein composed of the diphtheria toxin (DT) without a receptor-binding domain and the C1, C2, and C3 (3C) domains of Streptococcus protein G. It is primarily employed for in vitro detection of the internalization efficiency of monoclonal antibodies by target cells.

Compared to common antibody internalization efficiency detection techniques such as acid buffer washout, mAb-ZAP method, pHrodo technology, etc., the DT3C recombinant protein assay for antibody internalization offers the advantages of simplicity, speed, and high detection efficiency.

Learn More Get one trail
Therapeutic Antibody Discovery Service
Therapeutic Antibody Discovery

CUSABIO has been dedicated to protein and antibody research and production for the past 16 years. We have successfully screened over 100 therapeutic antibody candidates for numerous pharmaceutical companies, with many progressing to the CMC or IND stages. Our excellent antigen preparation technology platform and extensive experience in antibody screening ensure that CUSABIO can provide you with a comprehensive one-stop solution from target identification to therapeutic antibody candidates, accelerating the entire drug development process.

Learn More
Custom Elisa Kit Service
Custom Elisa Kit Service

In the Antibody Discovery and Optimization stage, techniques such as antibody molecule screening, pharmacokinetic analysis, and immunogenicity analysis often utilize ELISA methods due to their simplicity, speed, and high throughput capabilities. Leveraging years of experience in ELISA development and a robust quality control system, CUSABIO offers a comprehensive one-stop service from antigen design to ELISA kit production. Our advanced technological platform allows us to customize high-quality ELISA kits tailored to your specific requirements. These kits are designed for the detection and screening of specific antibodies, as well as antibody property assessment.

Chat Now

Quality Control Stage

The payload is a critical component of ADC drugs, exerting its effects by interacting with specific molecules on tumor cells, disrupting their cellular functions, inhibiting growth and division, and ultimately achieving the goal of killing cancer cells. In the quality control stage of ADC drug development, anti-payload antibodies are employed for the immunological analysis of the payload in ADC drugs. Their role is to assess the stability, safety, and effectiveness of ADC drugs.

Anti-Payload Antibodies
DT3C Recombinant Protein

Exatecan derivative for ADC(DXD) is an inhibitor targeting DNA topoisomerase I, belonging to the camptothecin (CPT) class of compounds. In the next-generation DXD-ADC drugs, DXD serves as the drug payload, effectively eliminating nearby tumor cells with a shortened half-life to reduce the occurrence of toxic side effects. The DXD Monoclonal Antibody developed by CUSABIO can efficiently assess the stability and release efficiency of DXD. It can be utilized for plasma/serum pharmacokinetic analysis of ADC drugs, determination of drug binding affinity, DAR value analysis, and efficacy assessment of ADC drugs.

Learn More Get one trail

Clinical Research Stage

In the clinical research stage of ADC drug development, CUSABIO offers Cytokine Detection ELISA kits for toxicology studies and cellular immune assessments. We provide stable cell line products and custom services for antibody drug activity screening and ADCC/ADCP functional verification. Additionally, we offer Anti-idiotype Antibody preparation services for pharmacokinetic analysis and immunogenicity analysis.

IS Series Cytokine Detection ELISA Kit
DT3C Recombinant Protein

Cytokine detection plays a pivotal role in the development of ADC drugs, particularly in the assessment of immunogenicity, pharmacodynamics research, and safety evaluation. CUSABIO has developed the IS series of Cytokine detection assay kits specifically for industrial clients, including pharmaceutical companies. Drawing on rich research and development experience and an independent research platform, we meticulously select high-performance raw materials, uphold stringent quality standards, and implement multiple quality control measures. Our products are suitable for a range of applications, including CRS detection, residual process material testing in drug manufacturing, pharmacokinetic experimental cell function evaluation, quality control in the development of cell therapy drugs, and pharmacological efficacy testing.

Learn More
Stable Cell Lines and Customization Services
DT3C Recombinant Protein

Through molecular biology cloning techniques, specific reporter genes (e.g., luciferase) are inserted into the chromosome of target cells. Following screening and cultivation, stable cell lines capable of expressing the reporter gene consistently are obtained. In the clinical research and development phase, stable cell lines play a crucial role in validating the functionality of ADCC (antibody-dependent cellular cytotoxicity) and ADCP (antibody-dependent cellular phagocytosis). These stable cell lines are utilized to assess the interaction between candidate drugs or biologics and immune cells, determining their ability to promote immune cell-mediated cytotoxicity or phagocytosis. By validating the ADCC/ADCP functionality of stable cell lines, the immunomodulatory effects of drugs can be evaluated, guiding the progression of preclinical development.

CUSABIO has years of experience in protein expression research and possesses extensive expertise in developing stable cell lines. We offer a comprehensive range of stable cell line products targeting common drug targets and provide one-stop services from gene sequencing to stable cell line delivery for overexpression stable cell lines and reporter gene cell lines, offering comprehensive solutions for stable cell line construction to recombinant protein production and beyond.

Click to view existing products Stable Cell Line Development Service
Custom Anti-idiotype Antibody Services
DT3C Recombinant Protein

Due to the similarities between anti-idiotype antibodies and anti-drug antibodies (ADAs), anti-idiotype antibodies can serve as positive controls in immunogenicity analysis for the quantification of total anti-drug antibodies. Additionally, in pharmacokinetic (PK) and pharmacodynamic (PD) analyses of antibody drugs, anti-idiotype antibodies can be used to detect the levels of antibody drugs in the blood (free, bound, and total forms).

CUSABIO now offers services for the preparation of polyclonal rabbit anti-idiotype antibodies and monoclonal mouse anti-idiotype antibodies (anti-Fab, anti-ScFv). Leveraging our five major protein expression platforms and assay kit development platform, we can provide customers with a comprehensive service ranging from antigen preparation and Anti-idiotype Antibody development to the establishment of detection methods and the development of assay kits.

Learn More
icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 322 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1